{"id":"W2032454683","doi":"10.1097/01.jto.0000283193.48953.cd","title":"C1-06: BO17704: a phase III study of first-line cisplatin and gemcitabine with bevacizumab or placebo in patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC)","year":2007,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; Royal Victoria Hospital","funders":"","keywords":"Medicine; Bevacizumab; Gemcitabine; Carboplatin; Internal medicine; Lung cancer; Oncology; Clinical endpoint; Regimen; Placebo; Progression-free survival; Chemotherapy; Cisplatin; Phases of clinical research; Surgery; Randomized controlled trial; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002182921,0.002546552,0.005665337,0.0009819574,0.0007613327,0.001602037,0.002185382,0.002698693,0.007897833],"category_scores_gemma":[0.00121196,0.001336893,0.002850494,0.0008764446,0.001868227,0.001626555,0.0006245706,0.008620395,0.002023969],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002122322,"about_ca_system_score_gemma":0.004074491,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004617052,"about_ca_topic_score_gemma":0.01324895,"domain_scores_codex":[0.9993331,0.0002833165,0.00003051341,0.0001099629,0.00004978853,0.0001933227],"domain_scores_gemma":[0.9990209,0.0001283521,0.0001326785,0.00005958818,0.00004810811,0.0006102935],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8601145,0.04505786,0.001957644,0.001033755,0.002225555,0.0001314174,0.000171847,0.001395184,0.01416398,0.0003109647,0.006219155,0.06721816],"study_design_scores_gemma":[0.8404536,0.1536264,0.002483117,0.00002374909,0.0004571759,0.00008947204,0.00002979452,0.0004534419,0.001008425,0.00007358555,0.001275893,0.00002535292],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9828061,0.00531326,0.0005697554,0.001620002,0.0005957527,0.003524714,0.002207406,0.0003751711,0.002987805],"genre_scores_gemma":[0.9725727,0.006728107,0.002420662,0.002277193,0.0006706595,0.003997096,0.00458223,0.0001254283,0.006625857],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007897833,"threshold_uncertainty_score":0.02642083,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02022585528329257,"score_gpt":0.4093997061687316,"score_spread":0.389173850885439,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}